JP2024009974A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024009974A5 JP2024009974A5 JP2023177929A JP2023177929A JP2024009974A5 JP 2024009974 A5 JP2024009974 A5 JP 2024009974A5 JP 2023177929 A JP2023177929 A JP 2023177929A JP 2023177929 A JP2023177929 A JP 2023177929A JP 2024009974 A5 JP2024009974 A5 JP 2024009974A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- composition according
- microorganism
- polypeptide
- hominis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762553025P | 2017-08-31 | 2017-08-31 | |
| US62/553,025 | 2017-08-31 | ||
| PCT/US2018/049237 WO2019046801A1 (en) | 2017-08-31 | 2018-08-31 | MOLECULAR BACTERIOTHERAPY FOR CONTROLLING THE ENZYMATIC ACTIVITY OF THE SKIN |
| JP2020511758A JP7373176B2 (ja) | 2017-08-31 | 2018-08-31 | 皮膚の酵素活性を制御する分子的細菌療法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020511758A Division JP7373176B2 (ja) | 2017-08-31 | 2018-08-31 | 皮膚の酵素活性を制御する分子的細菌療法 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2024009974A JP2024009974A (ja) | 2024-01-23 |
| JP2024009974A5 true JP2024009974A5 (https=) | 2024-02-20 |
| JP7720639B2 JP7720639B2 (ja) | 2025-08-08 |
| JP7720639B6 JP7720639B6 (ja) | 2025-09-18 |
Family
ID=65527832
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020511758A Active JP7373176B2 (ja) | 2017-08-31 | 2018-08-31 | 皮膚の酵素活性を制御する分子的細菌療法 |
| JP2023177929A Active JP7720639B6 (ja) | 2017-08-31 | 2023-10-14 | 皮膚の酵素活性を制御する分子的細菌療法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020511758A Active JP7373176B2 (ja) | 2017-08-31 | 2018-08-31 | 皮膚の酵素活性を制御する分子的細菌療法 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20210177917A1 (https=) |
| EP (1) | EP3675884A4 (https=) |
| JP (2) | JP7373176B2 (https=) |
| KR (1) | KR20200083435A (https=) |
| CN (1) | CN111295196A (https=) |
| AU (1) | AU2018326791B2 (https=) |
| BR (1) | BR112020003508A2 (https=) |
| CA (1) | CA3072772A1 (https=) |
| MX (1) | MX2020002013A (https=) |
| WO (1) | WO2019046801A1 (https=) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3072899B1 (en) * | 2015-03-23 | 2018-05-02 | Eberhard Karls Universität Tübingen | Novel anti-infective compound |
| JP7678518B2 (ja) * | 2019-06-21 | 2025-05-16 | ポーラ化成工業株式会社 | スタフィロコッカス・ホミニス（Ｓｔａｐｈｙｌｏｃｏｃｃｕｓ ｈｏｍｉｎｉｓ）を有効成分とする肌状態改善剤 |
| KR102195996B1 (ko) * | 2019-09-27 | 2020-12-29 | 코스맥스 주식회사 | 스타필로코커스 와르네리 st-12 균주 및 그의 피부 상태 개선 용도 |
| KR102286076B1 (ko) * | 2019-09-27 | 2021-08-05 | 코스맥스 주식회사 | 스타필로코커스 갈리나룸 st-4 균주 및 그의 피부 상태 개선 용도 |
| KR102199065B1 (ko) * | 2019-09-27 | 2021-01-06 | 코스맥스 주식회사 | 스타필로코커스 코니이 st-3 균주 및 그의 피부 상태 개선 용도 |
| KR102195998B1 (ko) * | 2019-09-27 | 2020-12-29 | 코스맥스 주식회사 | 스타필로코커스 시뮬란스 st-9 균주 및 그의 피부 상태 개선 용도 |
| KR102286075B1 (ko) * | 2019-09-27 | 2021-08-05 | 코스맥스 주식회사 | 스타필로코커스 렌투스 st-2 균주 및 그의 피부 상태 개선 용도 |
| KR102286077B1 (ko) * | 2019-09-27 | 2021-08-05 | 코스맥스 주식회사 | 스타필로코커스 에피더미디스 st-6 균주 및 그의 피부 상태 개선 용도 |
| KR102199062B1 (ko) * | 2019-09-27 | 2021-01-06 | 코스맥스 주식회사 | 스타필로코커스 자일로서스 st-10 균주 및 그의 피부 상태 개선 용도 |
| KR102195995B1 (ko) * | 2019-09-27 | 2020-12-29 | 코스맥스 주식회사 | 스타필로코커스 슐레이페리 st-13 균주 및 그의 피부 상태 개선 용도 |
| KR102233385B1 (ko) * | 2019-09-27 | 2021-03-29 | 코스맥스 주식회사 | 스타필로코커스 캐피티스 st-1 균주 및 그의 피부 상태 개선 용도 |
| KR20220133262A (ko) * | 2020-01-29 | 2022-10-04 | 더 잭슨 래보라토리 | 박테리아 혼합물 |
| CN111870225A (zh) * | 2020-08-04 | 2020-11-03 | 中国科学技术大学 | 一种用于荧光标定的标准模板制作方法 |
| WO2022087065A1 (en) * | 2020-10-21 | 2022-04-28 | The Jackson Laboratory | Antimicrobial biosensors |
| CN112778399A (zh) * | 2021-01-21 | 2021-05-11 | 南开大学 | 一类源自毒性淀粉样纤维纳米抗菌肽的制备及性质表征方法 |
| WO2022187724A1 (en) * | 2021-03-05 | 2022-09-09 | The Regents Of The University Of California | Skin probiotics |
| CN113234125B (zh) * | 2021-05-10 | 2022-12-06 | 华东理工大学 | 自组装多肽、多肽水凝胶及其制备方法和用途 |
| CN113730648B (zh) * | 2021-09-06 | 2022-11-01 | 温州瑞司特生物科技有限公司 | 结合表皮葡萄球菌的水凝胶及其在治疗创面中的应用 |
| KR102609655B1 (ko) * | 2022-07-27 | 2023-12-06 | 코스맥스 주식회사 | 스트렙토코커스 소브리너스 균주 및 그의 피부 상태 개선 용도 |
| KR102855517B1 (ko) * | 2022-06-03 | 2025-09-05 | 코스맥스 주식회사 | 스타필로코커스 코흐니 균주 및 그의 피부 상태 개선 용도 |
| KR102609656B1 (ko) * | 2022-06-03 | 2023-12-06 | 코스맥스 주식회사 | 스타필로코커스 호미니스 균주 및 그의 피부 상태 개선 용도 |
| KR102855516B1 (ko) * | 2022-06-03 | 2025-09-08 | 코스맥스 주식회사 | 스타필로코커스 아우리큘라리스 균주 및 그의 피부 상태 개선 용도 |
| CN116515662A (zh) * | 2022-08-05 | 2023-08-01 | 山东福瑞达生物股份有限公司 | 一株抗炎阿尔莱特葡萄球菌及其应用 |
| WO2024158103A1 (ko) * | 2023-01-25 | 2024-08-02 | 코스맥스 주식회사 | 스트렙토코커스 속 균주를 포함하는 피부 질환의 예방, 개선 또는 치료용 조성물 |
| CN116694535B (zh) * | 2023-07-20 | 2024-08-23 | 四川大学 | 一种戊糖乳杆菌w19及其应用 |
| WO2025240841A1 (en) * | 2024-05-16 | 2025-11-20 | The Regents Of The University Of California | Antimicrobial therapy |
| CN119326709A (zh) * | 2024-11-07 | 2025-01-21 | 中国医学科学院皮肤病医院(中国医学科学院皮肤病研究所) | 一种表皮葡萄球菌h62-3代谢产物凝胶制剂及其制备方法与应用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US300A (en) | 1837-07-29 | Machine foe spinning woolen roving | ||
| US113A (en) | 1837-01-31 | Improvement in the mode of making or preparing door-plates | ||
| GB2208511A (en) | 1987-08-07 | 1989-04-05 | Bayer Ag | Variants of bovine pancreatic trypsin inhibitor produced by recombinant dna technology |
| US5464820A (en) | 1993-06-22 | 1995-11-07 | The University Hospital | Specific inhibitors of tissue kallikrein |
| US5786328A (en) | 1995-06-05 | 1998-07-28 | Genentech, Inc. | Use of kunitz type plasma kallikrein inhibitors |
| CA2256465A1 (en) * | 1996-05-22 | 1997-11-27 | New York University | Blocking expression of virulence factors in s. aureus |
| WO2007001982A1 (en) * | 2005-06-20 | 2007-01-04 | Archer-Daniels-Midland Company | Altered glyoxylate shunt for improved production of aspartate-derived amino acids and chemicals |
| CA2620022A1 (en) * | 2005-08-31 | 2007-03-08 | Serentis Limited | Use of an aureolysin inhibitor for the treatment of inflammatory skin conditions characterised by colonisation with staphylococcus aureus |
| KR101557173B1 (ko) * | 2007-10-25 | 2015-10-05 | 더 스크립스 리서치 인스티튜트 | 박테리아에서의 쿼럼 센싱의 항체 매개성 파괴 |
| AU2009323996A1 (en) * | 2008-12-03 | 2011-07-07 | Institut Pasteur | Use of phenol-soluble modulins for vaccine development |
| US20120064125A1 (en) * | 2009-04-17 | 2012-03-15 | Horswill Alexander R | Agr-mediated inhibition of methicillin resistant staphylococcus aureus |
| EP3613430A2 (en) * | 2013-10-11 | 2020-02-26 | Servizo Galego De Saúde (Sergas) | Live attenuated vaccines |
| US20160338979A1 (en) * | 2014-01-10 | 2016-11-24 | The Regents Of The University Of California | Skin probiotic |
| WO2015183683A2 (en) * | 2014-05-27 | 2015-12-03 | Indiana University Research And Technology Corporation | Peptide antagonist of ll-37 |
| EP4144756A1 (en) * | 2014-05-30 | 2023-03-08 | Azitra, Inc. | Therapeutic treatment of skin disease with recombinant commensal skin microorganisms |
| WO2017192442A2 (en) * | 2016-05-01 | 2017-11-09 | Wisconsin Alumni Research Foundation | Peptidic modulators of quorum sensing in staphyloccoccus epidermidis |
| WO2017197303A1 (en) * | 2016-05-13 | 2017-11-16 | University Of North Carolina At Greensboro | Methods and compositions for the inhibition of quorum sensing in bacterial infections |
-
2018
- 2018-08-31 MX MX2020002013A patent/MX2020002013A/es unknown
- 2018-08-31 US US16/642,340 patent/US20210177917A1/en not_active Abandoned
- 2018-08-31 AU AU2018326791A patent/AU2018326791B2/en active Active
- 2018-08-31 KR KR1020207007412A patent/KR20200083435A/ko not_active Ceased
- 2018-08-31 CA CA3072772A patent/CA3072772A1/en active Pending
- 2018-08-31 JP JP2020511758A patent/JP7373176B2/ja active Active
- 2018-08-31 WO PCT/US2018/049237 patent/WO2019046801A1/en not_active Ceased
- 2018-08-31 CN CN201880065645.XA patent/CN111295196A/zh active Pending
- 2018-08-31 BR BR112020003508-4A patent/BR112020003508A2/pt not_active Application Discontinuation
- 2018-08-31 EP EP18849932.1A patent/EP3675884A4/en active Pending
-
2023
- 2023-10-14 JP JP2023177929A patent/JP7720639B6/ja active Active
- 2023-10-25 US US18/494,552 patent/US20240325460A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024009974A5 (https=) | ||
| JP2021013395A5 (https=) | ||
| CA3132858A1 (en) | Compositions and methods for improving skin health and for the treatment and prevention of diseases, disorders and conditions associated with pathogenic microbes | |
| JP2022501330A5 (https=) | ||
| GB2589729A (en) | Compositions for the treatment of skin conditions | |
| MX2020013275A (es) | Nuevos compuestos y sus composiciones farmaceuticas para el tratamiento de enfermedades. | |
| JP2022507616A5 (https=) | ||
| CA3195341A1 (en) | Compositions and methods for improving skin health and for the treatment and prevention of diseases, disorders and conditions associated with fungi and other pathogenic microbes | |
| SA522440072B1 (ar) | (Cutibacterium acnes) سلالة البكتيريا البروبيونية العدية واستخدامات طبية لها | |
| WO2023178194A3 (en) | Novel microbial composition and methods of use thereof | |
| WO2017199022A4 (en) | Lactobacillus rhamnosus lysate compositions and uses thereof | |
| da Silva Oliveira et al. | Nisin variants: What makes them different and unique? | |
| CN120284830A (zh) | 新的皮肤护理组合物 | |
| US20250312314A1 (en) | Method and composition for improving or maintaining skin health of mammals | |
| US11766465B2 (en) | External composition for wound healing containing lactobacillus fermentation product and method for promoting wound healing using the same | |
| CN114929196A (zh) | 新的皮肤护理组合物 | |
| KR102842460B1 (ko) | 리시놀레산을 포함하는 항생제 감수성 증진용 조성물 | |
| KR102803303B1 (ko) | 움벨리페론 또는 이의 유도체를 포함하는 피부 미생물 균총 개선용 조성물 | |
| CA2979079C (en) | Therapeutic treatment of skin disease with recombinant commensal skin microorganisms | |
| JP2024544960A5 (https=) | ||
| KR102356534B1 (ko) | 하고초 추출물을 함유하는 바이오필름 형성 억제용 조성물 | |
| Lee et al. | Skin-infected Bactericidal Activity of Antimicrobial Peptide against Multidrug-resistant Staphylococcus aureus | |
| Saravanakumar et al. | Integrated discovery and bioengineering of Halcarins, antimicrobial peptides from sea anemone with broad-spectrum therapeutic potential | |
| KR102298377B1 (ko) | 택란 추출물을 함유하는 바이오필름 형성 억제용 조성물 | |
| PL435199A1 (pl) | Kompozycja bakteriofagów specyficzna wobec bakterii z rodziny Enterobacterlaceae, zwłaszcza Escherichia coli, zastosowanie kompozycji bakteriofagów do leczenia zakażeń wywołanych przez bakterie z rodziny Enterobacterlaceae, zwłaszcza Escherichia coli oraz zastosowanie kompozycji bakteriofagów jako czynnika biokontroli |